Swissmedic Issues Recall for GlucoSaline B. Braun Infusion Solution Batch
Swissmedic has announced a recall of batch number 242867651 for the product GlucoSaline B. Braun Infusion Solution. This action affects […]
Swissmedic has announced a recall of batch number 242867651 for the product GlucoSaline B. Braun Infusion Solution. This action affects […]
Swissmedic has announced a significant update regarding the publication of safety-related revisions to product information. Effective November 2025, clinicians, regulatory
Swissmedic has granted the first authorisation for ZYNYZ®, marking a significant regulatory milestone. This development signals an important step for
On November 14, 2025, Swissmedic officially announced the first authorization of DATROWAY®, marking an important step in regulatory approvals for
On November 14, 2025, Swissmedic officially announced the first regulatory authorization of Pylclari®, marking an important step in medical device
Swissmedic, Switzerland’s regulatory authority for therapeutic products, has announced the authorization of an extended therapeutic indication for Enhertu®. This update
A groundbreaking clinical trial is underway to evaluate how remote technology can predict and prevent negative outcomes during the transition
A new clinical trial focusing on peripheral intravenous (IV) infiltration detection is set to advance the landscape of medical device
A completed clinical trial has shed new light on the effectiveness of humeral head depressor exercises for individuals diagnosed with
On November 14, 2025, Poitiers University Hospital announced plans for an innovative clinical trial studying a new non-invasive method to